HVC
Healthcare Value Capital Portfolio holdings
AUM
$38.5M
This Quarter Return
+11.08%
1 Year Return
+22.29%
3 Year Return
+31.09%
5 Year Return
+125.72%
10 Year Return
–
AUM
$61.6M
AUM Growth
+$61.6M
(+1.6%)
Cap. Flow
-$7.92M
Cap. Flow
% of AUM
-12.86%
Top 10 Holdings %
Top 10 Hldgs %
81.25%
Holding
48
New
4
Increased
8
Reduced
3
Closed
12
Top Buys
| 1 |
Supernus Pharmaceuticals
SUPN
|
$1.39M |
| 2 |
Baxter International
BAX
|
$1.39M |
| 3 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$1.04M |
| 4 |
QLTI
QLT Inc
QLTI
|
$621K |
| 5 |
Rigel Pharmaceuticals
RIGL
|
$570K |
Top Sells
| 1 |
GIVN
GIVEN IMAGING LTD
GIVN
|
$2.11M |
| 2 |
Humana
HUM
|
$1.87M |
| 3 |
SLTM
SOLTA MED INC (DE)
SLTM
|
$1.85M |
| 4 |
AGN
Allergan plc
AGN
|
$1.8M |
| 5 |
ANI Pharmaceuticals
ANIP
|
$1.38M |
Sector Composition
| 1 | Healthcare | 79.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
ANI Pharmaceuticals
ANIP
$2.03B
| $9.75M | 7.15% | 485,410 -68,678 | -12% | -$1.38M |
|
|
2
Supernus Pharmaceuticals
SUPN
$2.53B
| $7.92M | 5.81% | 1,050,745 +185,000 | +21% | +$1.39M |
|
|
AUXL
3
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $6.93M | 5.09% | 334,481 +50,000 | +18% | +$1.04M |
|
4
AstraZeneca
AZN
$248B
| $4.88M | 3.58% | 82,239 | – | – |
|
|
FRX
5
DELISTED
FOREST LABORATORIES INC
FRX
| $4.23M | 3.1% | 70,382 | – | – |
|
6
Quest Diagnostics
DGX
$20.3B
| $4.13M | 3.03% | 77,208 +10,000 | +15% | +$535K |
|
7
Merck
MRK
$210B
| $3.85M | 2.83% | 77,000 +10,000 | +15% | +$501K |
|
|
HNT
8
DELISTED
HEALTH NET INC
HNT
| $2.97M | 2.18% | 100,000 | – | – |
|
|
QLTI
9
DELISTED
QLT Inc
QLTI
| $2.93M | 2.15% | 526,639 +111,500 | +27% | +$621K |
|
10
GSK
GSK
$79.9B
| $2.45M | 1.8% | 45,966 | – | – |
|
11
Teva Pharmaceuticals
TEVA
$21.1B
| $2.2M | 1.62% | 55,000 +5,000 | +10% | +$200K |
|
12
Sanofi
SNY
$121B
| $1.76M | 1.29% | 32,735 | – | – |
|
|
SGNT
13
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $1.49M | 1.09% | 58,722 -15,100 | -20% | -$383K |
|
|
14
Baxter International
BAX
$12.7B
| $1.39M | 1.02% | +20,000 | New | +$1.39M |
|
|
VXRT
15
DELISTED
Vaxart
VXRT
| $857K | 0.63% | 204,639 +23,410 | +13% | +$98K |
|
|
ZGNX
16
DELISTED
Zogenix, Inc.
ZGNX
| $607K | 0.45% | 176,336 -100,000 | -36% | -$344K |
|
17
Amicus Therapeutics
FOLD
$2.34B
| $588K | 0.43% | 250,000 +115,000 | +85% | +$270K |
|
|
18
Rigel Pharmaceuticals
RIGL
$697M
| $570K | 0.42% | +200,000 | New | +$570K |
|
|
KIN
19
DELISTED
Kindred Biosciences, Inc.
KIN
| $559K | 0.41% | +50,000 | New | +$559K |
|
|
XNPT
20
DELISTED
XENOPORT, INC.
XNPT
| $443K | 0.33% | +77,000 | New | +$443K |
|
|
VIRX
21
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $394K | 0.29% | 83,185 | – | – |
|
22
Cytokinetics
CYTK
$4.23B
| $368K | 0.27% | 56,666 | – | – |
|
|
STML
23
DELISTED
Stemline Therapeutics, Inc.
STML
| $323K | 0.24% | 16,464 | – | – |
|
24
Artivion
AORT
$2.07B
| – | – | -118,288 | Closed | -$828K |
|
25
Elevance Health
ELV
$71.8B
| – | – | -15,000 | Closed | -$1.25M |
|